ストックスクリーナーアプリを入手
2.8131
1.55%
0.0431
Xenetic Biosciences Inc (XBIO) 最新ニュース
Xenetic Biosciences Inc expected to post a loss of 72 cents a shareEarnings Preview - TradingView
Xenetic Biosciences, Inc. Announces Executive Leadership Transition - ACCESS Newswire
Press Release Distribution & PR Platform - ACCESS Newswire
Xenetic Biosciences (XBIO) to Release Earnings on Thursday - Defense World
Xenetic Biosciences, Inc. Reports 2018 Year End Results and Provides Corporate Update - ACCESS Newswire
Xenetic Biosciences, Inc. Extends Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology Platform - ACCESS Newswire
Xenetic Biosciences, Inc. Reports First Quarter 2021 Financial Results - ACCESS Newswire
Xenetic Biosciences, Inc. Appoints Accomplished Biopharmaceutical Executive, Greg MacMichael, Ph.D. to Scientific Advisory Board - ACCESS Newswire
Xenetic Biosciences, Inc. Receives Approval to Commence Exploratory Study of XCART(TM) - ACCESS Newswire
Xenetic Biosciences Inc (NASDAQ:XBIO) Short Interest Update - Defense World
Analyzing Ampio Pharmaceuticals (NYSE:AMPE) & Xenetic Biosciences (NASDAQ:XBIO) - Defense World
Xenetic Biosciences (NASDAQ:XBIO) Earns Neutral Rating from HC Wainwright - Defense World
Xenetic Biosciences appoints new accounting firm By Investing.com - Investing.com Canada
Xenetic Biosciences appoints new accounting firm - Investing.com
Wainwright maintains Neutral on Xenetic shares after segment - Investing.com
Wainwright maintains Neutral on Xenetic shares after segment By Investing.com - Investing.com South Africa
Xenetic Biosciences, Inc. Releases Virtual Investor "What This M - GuruFocus
Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment - guardonline.com
1.72%
0.85%
大文字化:
|
ボリューム (24 時間):